lifestyle.celebhomes.net
Home
Sample Page
Author:
Sanofi Winthrop Industrie
Press Release: AAD: new results from Sanofi’s amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
March 30, 2026
Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
March 27, 2026
Press release: Availability of the Q1 2026 aide-mémoire
March 24, 2026
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
March 24, 2026
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
March 18, 2026
Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion
February 3, 2026
Communiqué de presse : Le CHMP recommande l’approbation du Rezurock de Sanofi dans l’UE pour le traitement de la maladie chronique du greffon contre l’hôte
January 30, 2026
Communiqué de presse : 2025 : année de forte croissance du chiffre d’affaires et du BNPA. Poursuite d’une croissance rentable attendue en 2026
January 29, 2026
←
Previous Page
1
2